Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells

References

• Maragakis NJ, Rothstein JD. Glutamate transporters in neurologic disease. Arch Neurol 2001; 58: 365–370.
   PubMedGoogle Scholar
• Almer G, Guegan C, Teismann P et al. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis. Ann Neurol 2001; 49: 176–185.
   Google Scholar
• Yasojima K, Tourtellotte WW, McGeer EG, McGeer PL. Marked increase in cyclooxygenase-2 in ALS spinal cord: implications for therapy. Neurology 2001; 57: 952–956.
   PubMed Web of Science ®Google Scholar
• Drachman DB, Frank K, Dykes-Hoberg M et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2002; 52: 771–778.
   Google Scholar
• Herschman HR, Reddy ST, Xie W. Function and regulation of prostaglandin synthase-2. Adv Exp Med Biol 1997; 407: 61–66.
   PubMed Web of Science ®Google Scholar
• Lewis RA, Austen KF, Soberman RJ. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N Engl J Med 1990; 323: 645–655.
   Google Scholar
• Almer G, Teismann P, Stevic Z et al. Increased levels of the pro- inflammatory prostaglandin PGE2 in CSF from ALS patients. Neurology 2002; 58: 1277–1279.
   Google Scholar
• Almer G, Vukosavic S, Romero N, Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 1999; 72: 2415–2425.
   PubMed Web of Science ®Google Scholar
• Drachman DB, Rothstein JD. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol 2000; 48: 792–795.
   PubMed Web of Science ®Google Scholar
• Esposito B, De Santis A, Monteforte R, Baccari GC. Mast cells in Wallerian degeneration: morphologic and ultrastructural changes. J Comp Neurol 2002; 445: 199–210.
   PubMedGoogle Scholar
• Shubayev VI, Myers RR. Up-regulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury. Brain Res 2000; 855: 83–89.
   PubMed Web of Science ®Google Scholar
• Skaper SD, Pollock M, Facci L. Mast cells differentially express and release active high molecular weight neurotrophins. Brain Res Mol Brain Res 2001; 97: 177–185.
   PubMedGoogle Scholar
• Skaper SD, Facci L, Romanello S, Leon A. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway. J Neurochem 1996; 66: 1157–1166.
   PubMedGoogle Scholar
• Bauer O, Razin E. Mast cell-nerve interactions. News Physiol Sci 2000; 15: 213–218.
   PubMedGoogle Scholar
• Rouleau A, Dimitriadou V, Trung Tuong MD et al. Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis. J Neural Transm 1997; 104: 399–417.
   Google Scholar
• Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol 1992; 140: 691–707.
   PubMed Web of Science ®Google Scholar
• Fiala M, Liu QN, Sayre J et al. Cyclooxygenase-2-positive macro- phages infiltrate the Alzheimer’s disease brain and damage the blood-brain barrier. Eur J Clin Invest 2002; 32: 360–371.
   Google Scholar
• Fiala M, Liu NQ, Reddy S, Graves M. Macrophages infiltrate the brain and express COX-2 and iNOS in Alzheimer’s disease and AIDS. Alzheimer’s Reports 2001; 4: 1–7.
   Google Scholar
• Twu C, Liu NQ, Popik W et al. Cardiomyocytes undergo apoptosis in human immunodeficiency virus cardiomyopathy through mitochondrion- and death receptor-controlled path- ways. Proc Natl Acad Sci USA 2002; 99: 14386–14391.
   Google Scholar
• Valle A, Zuber CE, Defrance T, Djossou O, De Rie M, Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 1989; 19: 1463–1467.
   PubMed Web of Science ®Google Scholar
• Hermann P, Van-Kooten C, Gaillard C, Banchereau J, Blanchard D. CD40 ligand-positive CD8+ T cell clones allow B cell growth and differentiation. Eur J Immunol 1995; 25: 2972–2977.
   PubMedGoogle Scholar
• McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer’s disease. Exp Gerontol 1998; 33: 371–378.
   PubMed Web of Science ®Google Scholar
• Akiyama H, Barger S, Barnum S et al. Inflammation and Alzheimer’s disease. Neurobiol Aging 2000; 21: 383–421.
   Google Scholar
• Jackson M, Llado J, Rothstein JD. Therapeutic developments in the treatment of amyotrophic lateral sclerosis. Expert Opin Investig Drugs 2002; 11: 1343–1164.
   PubMed Web of Science ®Google Scholar
• Hayashi S, Sakurai A, Amari M, Okamoto K. Pathological study of the diffuse myelin pallor in the anterolateral columns of the spinal cord in amyotrophic lateral sclerosis. J Neurol Sci 2001; 188: 3–7.
   PubMedGoogle Scholar
• Elliott JL. Cytokine up-regulation in a murine model of familial amyotrophic lateral sclerosis. Brain Res Mol Brain Res 2001; 95: 172–178.
   PubMedGoogle Scholar
• Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 2001; 57: 1282–1289.
   PubMed Web of Science ®Google Scholar
• Tikka TM, Vartiainen NE, Goldsteins G et al. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 2002; 125: 722–731.
   Google Scholar
• Sanchez-Mejorada G, Alonso-deFlorida F. Changes in mast cell distribution in skeletal muscle after denervation. Muscle Nerve 1992; 15: 716–719.
   PubMedGoogle Scholar
• Garlichs CD, Geis T, Goppelt-Struebe M et al. Induction of cyclooxygenase-2 and enhanced release of prostaglandin E(2) and I(2) in human endothelial cells by engagement of CD40. Atherosclerosis 2002; 163: 9–16.
   Google Scholar
• Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature 1990; 346: 274–276.
   PubMed Web of Science ®Google Scholar
• Fiala M, Zhang L, Gan X-H et al. Amyloid-beta induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Molecular Medicine 1998; 4: 480–489.
   Google Scholar
• Kunst CB, Mezey E, Brownstein MJ, Patterson D. Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions. Nat Genet 1997; 15: 91–94.
   PubMed Web of Science ®Google Scholar
• Wiedau-Pazos M, Goto JJ, Rabizadeh S et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996; 271: 515–518.
   Google Scholar
• Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyo- trophic lateral sclerosis neural tissues. Neurobiol Dis 2001; 8: 933–941.
   PubMed Web of Science ®Google Scholar
• Son M, Cloyd CD, Rothstein JD, Rajendran B, Elliott JL. Aggregate formation in Cu/Zn superoxide dismutase-related proteins. J Biol Chem 2003; 278: 14331–14336.
   PubMed Web of Science ®Google Scholar